Global Kinase Inhibitors Market Insights and Forecast to 2028

Report ID: 1197276 | Published Date: Jan 2025 | No. of Page: 128 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Kinase Inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Non-receptor Tyrosine Kinase Inhibitors
        1.2.3 Receptor Tyrosine Kinase Inhibitors
        1.2.4 Multikinase Inhibitors
        1.2.5 Serine/Threonine Kinase Inhibitors
        1.2.6 Protein Kinase C Inhibitors
        1.2.7 RHO Kinase Inhibitors
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Kinase Inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Oncology
        1.3.3 Inflammatory Diseases
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Kinase Inhibitors Market Perspective (2017-2028)
    2.2 Kinase Inhibitors Growth Trends by Region
        2.2.1 Kinase Inhibitors Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Kinase Inhibitors Historic Market Size by Region (2017-2022)
        2.2.3 Kinase Inhibitors Forecasted Market Size by Region (2023-2028)
    2.3 Kinase Inhibitors Market Dynamics
        2.3.1 Kinase Inhibitors Industry Trends
        2.3.2 Kinase Inhibitors Market Drivers
        2.3.3 Kinase Inhibitors Market Challenges
        2.3.4 Kinase Inhibitors Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Kinase Inhibitors Players by Revenue
        3.1.1 Global Top Kinase Inhibitors Players by Revenue (2017-2022)
        3.1.2 Global Kinase Inhibitors Revenue Market Share by Players (2017-2022)
    3.2 Global Kinase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Kinase Inhibitors Revenue
    3.4 Global Kinase Inhibitors Market Concentration Ratio
        3.4.1 Global Kinase Inhibitors Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Kinase Inhibitors Revenue in 2021
    3.5 Kinase Inhibitors Key Players Head office and Area Served
    3.6 Key Players Kinase Inhibitors Product Solution and Service
    3.7 Date of Enter into Kinase Inhibitors Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Kinase Inhibitors Breakdown Data by Type
    4.1 Global Kinase Inhibitors Historic Market Size by Type (2017-2022)
    4.2 Global Kinase Inhibitors Forecasted Market Size by Type (2023-2028)
5 Kinase Inhibitors Breakdown Data by Application
    5.1 Global Kinase Inhibitors Historic Market Size by Application (2017-2022)
    5.2 Global Kinase Inhibitors Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Kinase Inhibitors Market Size (2017-2028)
    6.2 North America Kinase Inhibitors Market Size by Type
        6.2.1 North America Kinase Inhibitors Market Size by Type (2017-2022)
        6.2.2 North America Kinase Inhibitors Market Size by Type (2023-2028)
        6.2.3 North America Kinase Inhibitors Market Share by Type (2017-2028)
    6.3 North America Kinase Inhibitors Market Size by Application
        6.3.1 North America Kinase Inhibitors Market Size by Application (2017-2022)
        6.3.2 North America Kinase Inhibitors Market Size by Application (2023-2028)
        6.3.3 North America Kinase Inhibitors Market Share by Application (2017-2028)
    6.4 North America Kinase Inhibitors Market Size by Country
        6.4.1 North America Kinase Inhibitors Market Size by Country (2017-2022)
        6.4.2 North America Kinase Inhibitors Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Kinase Inhibitors Market Size (2017-2028)
    7.2 Europe Kinase Inhibitors Market Size by Type
        7.2.1 Europe Kinase Inhibitors Market Size by Type (2017-2022)
        7.2.2 Europe Kinase Inhibitors Market Size by Type (2023-2028)
        7.2.3 Europe Kinase Inhibitors Market Share by Type (2017-2028)
    7.3 Europe Kinase Inhibitors Market Size by Application
        7.3.1 Europe Kinase Inhibitors Market Size by Application (2017-2022)
        7.3.2 Europe Kinase Inhibitors Market Size by Application (2023-2028)
        7.3.3 Europe Kinase Inhibitors Market Share by Application (2017-2028)
    7.4 Europe Kinase Inhibitors Market Size by Country
        7.4.1 Europe Kinase Inhibitors Market Size by Country (2017-2022)
        7.4.2 Europe Kinase Inhibitors Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Kinase Inhibitors Market Size (2017-2028)
    8.2 Asia-Pacific Kinase Inhibitors Market Size by Type
        8.2.1 Asia-Pacific Kinase Inhibitors Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Kinase Inhibitors Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Kinase Inhibitors Market Share by Type (2017-2028)
    8.3 Asia-Pacific Kinase Inhibitors Market Size by Application
        8.3.1 Asia-Pacific Kinase Inhibitors Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Kinase Inhibitors Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Kinase Inhibitors Market Share by Application (2017-2028)
    8.4 Asia-Pacific Kinase Inhibitors Market Size by Region
        8.4.1 Asia-Pacific Kinase Inhibitors Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Kinase Inhibitors Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Kinase Inhibitors Market Size (2017-2028)
    9.2 Latin America Kinase Inhibitors Market Size by Type
        9.2.1 Latin America Kinase Inhibitors Market Size by Type (2017-2022)
        9.2.2 Latin America Kinase Inhibitors Market Size by Type (2023-2028)
        9.2.3 Latin America Kinase Inhibitors Market Share by Type (2017-2028)
    9.3 Latin America Kinase Inhibitors Market Size by Application
        9.3.1 Latin America Kinase Inhibitors Market Size by Application (2017-2022)
        9.3.2 Latin America Kinase Inhibitors Market Size by Application (2023-2028)
        9.3.3 Latin America Kinase Inhibitors Market Share by Application (2017-2028)
    9.4 Latin America Kinase Inhibitors Market Size by Country
        9.4.1 Latin America Kinase Inhibitors Market Size by Country (2017-2022)
        9.4.2 Latin America Kinase Inhibitors Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Kinase Inhibitors Market Size (2017-2028)
    10.2 Middle East & Africa Kinase Inhibitors Market Size by Type
        10.2.1 Middle East & Africa Kinase Inhibitors Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Kinase Inhibitors Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Kinase Inhibitors Market Share by Type (2017-2028)
    10.3 Middle East & Africa Kinase Inhibitors Market Size by Application
        10.3.1 Middle East & Africa Kinase Inhibitors Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Kinase Inhibitors Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Kinase Inhibitors Market Share by Application (2017-2028)
    10.4 Middle East & Africa Kinase Inhibitors Market Size by Country
        10.4.1 Middle East & Africa Kinase Inhibitors Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Kinase Inhibitors Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Details
        11.1.2 Merck Business Overview
        11.1.3 Merck Kinase Inhibitors Introduction
        11.1.4 Merck Revenue in Kinase Inhibitors Business (2017-2022)
        11.1.5 Merck Recent Developments
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Kinase Inhibitors Introduction
        11.2.4 Novartis Revenue in Kinase Inhibitors Business (2017-2022)
        11.2.5 Novartis Recent Developments
    11.3 Pfizer
        11.3.1 Pfizer Company Details
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Kinase Inhibitors Introduction
        11.3.4 Pfizer Revenue in Kinase Inhibitors Business (2017-2022)
        11.3.5 Pfizer Recent Developments
    11.4 Sanofi
        11.4.1 Sanofi Company Details
        11.4.2 Sanofi Business Overview
        11.4.3 Sanofi Kinase Inhibitors Introduction
        11.4.4 Sanofi Revenue in Kinase Inhibitors Business (2017-2022)
        11.4.5 Sanofi Recent Developments
    11.5 GlaxoSmithKline
        11.5.1 GlaxoSmithKline Company Details
        11.5.2 GlaxoSmithKline Business Overview
        11.5.3 GlaxoSmithKline Kinase Inhibitors Introduction
        11.5.4 GlaxoSmithKline Revenue in Kinase Inhibitors Business (2017-2022)
        11.5.5 GlaxoSmithKline Recent Developments
    11.6 Biogen Idec
        11.6.1 Biogen Idec Company Details
        11.6.2 Biogen Idec Business Overview
        11.6.3 Biogen Idec Kinase Inhibitors Introduction
        11.6.4 Biogen Idec Revenue in Kinase Inhibitors Business (2017-2022)
        11.6.5 Biogen Idec Recent Developments
    11.7 Bayer Healthcare Pharmaceuticals
        11.7.1 Bayer Healthcare Pharmaceuticals Company Details
        11.7.2 Bayer Healthcare Pharmaceuticals Business Overview
        11.7.3 Bayer Healthcare Pharmaceuticals Kinase Inhibitors Introduction
        11.7.4 Bayer Healthcare Pharmaceuticals Revenue in Kinase Inhibitors Business (2017-2022)
        11.7.5 Bayer Healthcare Pharmaceuticals Recent Developments
    11.8 Johnson
        11.8.1 Johnson Company Details
        11.8.2 Johnson Business Overview
        11.8.3 Johnson Kinase Inhibitors Introduction
        11.8.4 Johnson Revenue in Kinase Inhibitors Business (2017-2022)
        11.8.5 Johnson Recent Developments
    11.9 Tolero Pharmaceutical
        11.9.1 Tolero Pharmaceutical Company Details
        11.9.2 Tolero Pharmaceutical Business Overview
        11.9.3 Tolero Pharmaceutical Kinase Inhibitors Introduction
        11.9.4 Tolero Pharmaceutical Revenue in Kinase Inhibitors Business (2017-2022)
        11.9.5 Tolero Pharmaceutical Recent Developments
    11.10 Astellas Pharma Inc
        11.10.1 Astellas Pharma Inc Company Details
        11.10.2 Astellas Pharma Inc Business Overview
        11.10.3 Astellas Pharma Inc Kinase Inhibitors Introduction
        11.10.4 Astellas Pharma Inc Revenue in Kinase Inhibitors Business (2017-2022)
        11.10.5 Astellas Pharma Inc Recent Developments
    11.11 Eli Lilly and Co
        11.11.1 Eli Lilly and Co Company Details
        11.11.2 Eli Lilly and Co Business Overview
        11.11.3 Eli Lilly and Co Kinase Inhibitors Introduction
        11.11.4 Eli Lilly and Co Revenue in Kinase Inhibitors Business (2017-2022)
        11.11.5 Eli Lilly and Co Recent Developments
    11.12 Incyte Corp
        11.12.1 Incyte Corp Company Details
        11.12.2 Incyte Corp Business Overview
        11.12.3 Incyte Corp Kinase Inhibitors Introduction
        11.12.4 Incyte Corp Revenue in Kinase Inhibitors Business (2017-2022)
        11.12.5 Incyte Corp Recent Developments
    11.13 AstraZeneca
        11.13.1 AstraZeneca Company Details
        11.13.2 AstraZeneca Business Overview
        11.13.3 AstraZeneca Kinase Inhibitors Introduction
        11.13.4 AstraZeneca Revenue in Kinase Inhibitors Business (2017-2022)
        11.13.5 AstraZeneca Recent Developments
    11.14 Bristol-Myers Squibb
        11.14.1 Bristol-Myers Squibb Company Details
        11.14.2 Bristol-Myers Squibb Business Overview
        11.14.3 Bristol-Myers Squibb Kinase Inhibitors Introduction
        11.14.4 Bristol-Myers Squibb Revenue in Kinase Inhibitors Business (2017-2022)
        11.14.5 Bristol-Myers Squibb Recent Developments
    11.15 Boehringer Ingelheim International GmbH
        11.15.1 Boehringer Ingelheim International GmbH Company Details
        11.15.2 Boehringer Ingelheim International GmbH Business Overview
        11.15.3 Boehringer Ingelheim International GmbH Kinase Inhibitors Introduction
        11.15.4 Boehringer Ingelheim International GmbH Revenue in Kinase Inhibitors Business (2017-2022)
        11.15.5 Boehringer Ingelheim International GmbH Recent Developments
    11.16 F. Hoffmann-La Roche Ltd
        11.16.1 F. Hoffmann-La Roche Ltd Company Details
        11.16.2 F. Hoffmann-La Roche Ltd Business Overview
        11.16.3 F. Hoffmann-La Roche Ltd Kinase Inhibitors Introduction
        11.16.4 F. Hoffmann-La Roche Ltd Revenue in Kinase Inhibitors Business (2017-2022)
        11.16.5 F. Hoffmann-La Roche Ltd Recent Developments
    11.17 Eisai Co., Ltd.
        11.17.1 Eisai Co., Ltd. Company Details
        11.17.2 Eisai Co., Ltd. Business Overview
        11.17.3 Eisai Co., Ltd. Kinase Inhibitors Introduction
        11.17.4 Eisai Co., Ltd. Revenue in Kinase Inhibitors Business (2017-2022)
        11.17.5 Eisai Co., Ltd. Recent Developments
    11.18 BerGenBio
        11.18.1 BerGenBio Company Details
        11.18.2 BerGenBio Business Overview
        11.18.3 BerGenBio Kinase Inhibitors Introduction
        11.18.4 BerGenBio Revenue in Kinase Inhibitors Business (2017-2022)
        11.18.5 BerGenBio Recent Developments
    11.19 Rigel Pharmaceuticals
        11.19.1 Rigel Pharmaceuticals Company Details
        11.19.2 Rigel Pharmaceuticals Business Overview
        11.19.3 Rigel Pharmaceuticals Kinase Inhibitors Introduction
        11.19.4 Rigel Pharmaceuticals Revenue in Kinase Inhibitors Business (2017-2022)
        11.19.5 Rigel Pharmaceuticals Recent Developments
    11.20 Mirati Therapeutics
        11.20.1 Mirati Therapeutics Company Details
        11.20.2 Mirati Therapeutics Business Overview
        11.20.3 Mirati Therapeutics Kinase Inhibitors Introduction
        11.20.4 Mirati Therapeutics Revenue in Kinase Inhibitors Business (2017-2022)
        11.20.5 Mirati Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Kinase Inhibitors Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Non-receptor Tyrosine Kinase Inhibitors
    Table 3. Key Players of Receptor Tyrosine Kinase Inhibitors
    Table 4. Key Players of Multikinase Inhibitors
    Table 5. Key Players of Serine/Threonine Kinase Inhibitors
    Table 6. Key Players of Protein Kinase C Inhibitors
    Table 7. Key Players of RHO Kinase Inhibitors
    Table 8. Key Players of Others
    Table 9. Global Kinase Inhibitors Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 10. Global Kinase Inhibitors Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Kinase Inhibitors Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global Kinase Inhibitors Market Share by Region (2017-2022)
    Table 13. Global Kinase Inhibitors Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global Kinase Inhibitors Market Share by Region (2023-2028)
    Table 15. Kinase Inhibitors Market Trends
    Table 16. Kinase Inhibitors Market Drivers
    Table 17. Kinase Inhibitors Market Challenges
    Table 18. Kinase Inhibitors Market Restraints
    Table 19. Global Kinase Inhibitors Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global Kinase Inhibitors Revenue Share by Players (2017-2022)
    Table 21. Global Top Kinase Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kinase Inhibitors as of 2021)
    Table 22. Ranking of Global Top Kinase Inhibitors Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by Kinase Inhibitors Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Kinase Inhibitors Product Solution and Service
    Table 26. Date of Enter into Kinase Inhibitors Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Kinase Inhibitors Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global Kinase Inhibitors Revenue Market Share by Type (2017-2022)
    Table 30. Global Kinase Inhibitors Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global Kinase Inhibitors Revenue Market Share by Type (2023-2028)
    Table 32. Global Kinase Inhibitors Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global Kinase Inhibitors Revenue Share by Application (2017-2022)
    Table 34. Global Kinase Inhibitors Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global Kinase Inhibitors Revenue Share by Application (2023-2028)
    Table 36. North America Kinase Inhibitors Market Size by Type (2017-2022) & (US$ Million)
    Table 37. North America Kinase Inhibitors Market Size by Type (2023-2028) & (US$ Million)
    Table 38. North America Kinase Inhibitors Market Size by Application (2017-2022) & (US$ Million)
    Table 39. North America Kinase Inhibitors Market Size by Application (2023-2028) & (US$ Million)
    Table 40. North America Kinase Inhibitors Market Size by Country (2017-2022) & (US$ Million)
    Table 41. North America Kinase Inhibitors Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Europe Kinase Inhibitors Market Size by Type (2017-2022) & (US$ Million)
    Table 43. Europe Kinase Inhibitors Market Size by Type (2023-2028) & (US$ Million)
    Table 44. Europe Kinase Inhibitors Market Size by Application (2017-2022) & (US$ Million)
    Table 45. Europe Kinase Inhibitors Market Size by Application (2023-2028) & (US$ Million)
    Table 46. Europe Kinase Inhibitors Market Size by Country (2017-2022) & (US$ Million)
    Table 47. Europe Kinase Inhibitors Market Size by Country (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Kinase Inhibitors Market Size by Type (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Kinase Inhibitors Market Size by Type (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Kinase Inhibitors Market Size by Application (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Kinase Inhibitors Market Size by Application (2023-2028) & (US$ Million)
    Table 52. Asia Pacific Kinase Inhibitors Market Size by Region (2017-2022) & (US$ Million)
    Table 53. Asia Pacific Kinase Inhibitors Market Size by Region (2023-2028) & (US$ Million)
    Table 54. Latin America Kinase Inhibitors Market Size by Type (2017-2022) & (US$ Million)
    Table 55. Latin America Kinase Inhibitors Market Size by Type (2023-2028) & (US$ Million)
    Table 56. Latin America Kinase Inhibitors Market Size by Application (2017-2022) & (US$ Million)
    Table 57. Latin America Kinase Inhibitors Market Size by Application (2023-2028) & (US$ Million)
    Table 58. Latin America Kinase Inhibitors Market Size by Country (2017-2022) & (US$ Million)
    Table 59. Latin America Kinase Inhibitors Market Size by Country (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Kinase Inhibitors Market Size by Type (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Kinase Inhibitors Market Size by Type (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Kinase Inhibitors Market Size by Application (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Kinase Inhibitors Market Size by Application (2023-2028) & (US$ Million)
    Table 64. Middle East and Africa Kinase Inhibitors Market Size by Country (2017-2022) & (US$ Million)
    Table 65. Middle East and Africa Kinase Inhibitors Market Size by Country (2023-2028) & (US$ Million)
    Table 66. Merck Company Details
    Table 67. Merck Business Overview
    Table 68. Merck Kinase Inhibitors Product
    Table 69. Merck Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 70. Merck Recent Developments
    Table 71. Novartis Company Details
    Table 72. Novartis Business Overview
    Table 73. Novartis Kinase Inhibitors Product
    Table 74. Novartis Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 75. Novartis Recent Developments
    Table 76. Pfizer Company Details
    Table 77. Pfizer Business Overview
    Table 78. Pfizer Kinase Inhibitors Product
    Table 79. Pfizer Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 80. Pfizer Recent Developments
    Table 81. Sanofi Company Details
    Table 82. Sanofi Business Overview
    Table 83. Sanofi Kinase Inhibitors Product
    Table 84. Sanofi Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 85. Sanofi Recent Developments
    Table 86. GlaxoSmithKline Company Details
    Table 87. GlaxoSmithKline Business Overview
    Table 88. GlaxoSmithKline Kinase Inhibitors Product
    Table 89. GlaxoSmithKline Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 90. GlaxoSmithKline Recent Developments
    Table 91. Biogen Idec Company Details
    Table 92. Biogen Idec Business Overview
    Table 93. Biogen Idec Kinase Inhibitors Product
    Table 94. Biogen Idec Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 95. Biogen Idec Recent Developments
    Table 96. Bayer Healthcare Pharmaceuticals Company Details
    Table 97. Bayer Healthcare Pharmaceuticals Business Overview
    Table 98. Bayer Healthcare Pharmaceuticals Kinase Inhibitors Product
    Table 99. Bayer Healthcare Pharmaceuticals Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 100. Bayer Healthcare Pharmaceuticals Recent Developments
    Table 101. Johnson Company Details
    Table 102. Johnson Business Overview
    Table 103. Johnson Kinase Inhibitors Product
    Table 104. Johnson Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 105. Johnson Recent Developments
    Table 106. Tolero Pharmaceutical Company Details
    Table 107. Tolero Pharmaceutical Business Overview
    Table 108. Tolero Pharmaceutical Kinase Inhibitors Product
    Table 109. Tolero Pharmaceutical Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 110. Tolero Pharmaceutical Recent Developments
    Table 111. Astellas Pharma Inc Company Details
    Table 112. Astellas Pharma Inc Business Overview
    Table 113. Astellas Pharma Inc Kinase Inhibitors Product
    Table 114. Astellas Pharma Inc Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 115. Astellas Pharma Inc Recent Developments
    Table 116. Eli Lilly and Co Company Details
    Table 117. Eli Lilly and Co Business Overview
    Table 118. Eli Lilly and Co Kinase Inhibitors Product
    Table 119. Eli Lilly and Co Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 120. Eli Lilly and Co Recent Developments
    Table 121. Incyte Corp Company Details
    Table 122. Incyte Corp Business Overview
    Table 123. Incyte Corp Kinase Inhibitors Product
    Table 124. Incyte Corp Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 125. Incyte Corp Recent Developments
    Table 126. AstraZeneca Company Details
    Table 127. AstraZeneca Business Overview
    Table 128. AstraZeneca Kinase Inhibitors Product
    Table 129. AstraZeneca Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 130. AstraZeneca Recent Developments
    Table 131. Bristol-Myers Squibb Company Details
    Table 132. Bristol-Myers Squibb Business Overview
    Table 133. Bristol-Myers Squibb Kinase Inhibitors Product
    Table 134. Bristol-Myers Squibb Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 135. Bristol-Myers Squibb Recent Developments
    Table 136. Boehringer Ingelheim International GmbH Company Details
    Table 137. Boehringer Ingelheim International GmbH Business Overview
    Table 138. Boehringer Ingelheim International GmbH Kinase Inhibitors Product
    Table 139. Boehringer Ingelheim International GmbH Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 140. Boehringer Ingelheim International GmbH Recent Developments
    Table 141. F. Hoffmann-La Roche Ltd Company Details
    Table 142. F. Hoffmann-La Roche Ltd Business Overview
    Table 143. F. Hoffmann-La Roche Ltd Kinase Inhibitors Product
    Table 144. F. Hoffmann-La Roche Ltd Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 145. F. Hoffmann-La Roche Ltd Recent Developments
    Table 146. Eisai Co., Ltd. Company Details
    Table 147. Eisai Co., Ltd. Business Overview
    Table 148. Eisai Co., Ltd. Kinase Inhibitors Product
    Table 149. Eisai Co., Ltd. Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 150. Eisai Co., Ltd. Recent Developments
    Table 151. BerGenBio Company Details
    Table 152. BerGenBio Business Overview
    Table 153. BerGenBio Kinase Inhibitors Product
    Table 154. BerGenBio Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 155. BerGenBio Recent Developments
    Table 156. Rigel Pharmaceuticals Company Details
    Table 157. Rigel Pharmaceuticals Business Overview
    Table 158. Rigel Pharmaceuticals Kinase Inhibitors Product
    Table 159. Rigel Pharmaceuticals Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 160. Rigel Pharmaceuticals Recent Developments
    Table 161. Mirati Therapeutics Company Details
    Table 162. Mirati Therapeutics Business Overview
    Table 163. Mirati Therapeutics Kinase Inhibitors Product
    Table 164. Mirati Therapeutics Revenue in Kinase Inhibitors Business (2017-2022) & (US$ Million)
    Table 165. Mirati Therapeutics Recent Developments
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Kinase Inhibitors Market Share by Type: 2021 VS 2028
    Figure 2. Non-receptor Tyrosine Kinase Inhibitors Features
    Figure 3. Receptor Tyrosine Kinase Inhibitors Features
    Figure 4. Multikinase Inhibitors Features
    Figure 5. Serine/Threonine Kinase Inhibitors Features
    Figure 6. Protein Kinase C Inhibitors Features
    Figure 7. RHO Kinase Inhibitors Features
    Figure 8. Others Features
    Figure 9. Global Kinase Inhibitors Market Share by Application: 2021 VS 2028
    Figure 10. Oncology Case Studies
    Figure 11. Inflammatory Diseases Case Studies
    Figure 12. Others Case Studies
    Figure 13. Kinase Inhibitors Report Years Considered
    Figure 14. Global Kinase Inhibitors Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Kinase Inhibitors Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Kinase Inhibitors Market Share by Region: 2021 VS 2028
    Figure 17. Global Kinase Inhibitors Market Share by Players in 2021
    Figure 18. Global Top Kinase Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kinase Inhibitors as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Kinase Inhibitors Revenue in 2021
    Figure 20. North America Kinase Inhibitors Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. North America Kinase Inhibitors Market Size Market Share by Type (2017-2028)
    Figure 22. North America Kinase Inhibitors Market Size Market Share by Application (2017-2028)
    Figure 23. North America Kinase Inhibitors Market Size Share by Country (2017-2028)
    Figure 24. United States Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Kinase Inhibitors Market Size YoY (2017-2028) & (US$ Million)
    Figure 27. Europe Kinase Inhibitors Market Size Market Share by Type (2017-2028)
    Figure 28. Europe Kinase Inhibitors Market Size Market Share by Application (2017-2028)
    Figure 29. Europe Kinase Inhibitors Market Size Share by Country (2017-2028)
    Figure 30. Germany Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. France Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. U.K. Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Italy Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Russia Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Nordic Countries Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Kinase Inhibitors Market Size YoY (2017-2028) & (US$ Million)
    Figure 37. Asia Pacific Kinase Inhibitors Market Size Market Share by Type (2017-2028)
    Figure 38. Asia Pacific Kinase Inhibitors Market Size Market Share by Application (2017-2028)
    Figure 39. Asia Pacific Kinase Inhibitors Market Size Share by Region (2017-2028)
    Figure 40. China Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Japan Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. South Korea Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Southeast Asia Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. India Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Australia Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Latin America Kinase Inhibitors Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Latin America Kinase Inhibitors Market Size Market Share by Type (2017-2028)
    Figure 48. Latin America Kinase Inhibitors Market Size Market Share by Application (2017-2028)
    Figure 49. Latin America Kinase Inhibitors Market Size Share by Country (2017-2028)
    Figure 50. Mexico Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Brazil Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Kinase Inhibitors Market Size YoY (2017-2028) & (US$ Million)
    Figure 53. Middle East and Africa Kinase Inhibitors Market Size Market Share by Type (2017-2028)
    Figure 54. Middle East and Africa Kinase Inhibitors Market Size Market Share by Application (2017-2028)
    Figure 55. Middle East and Africa Kinase Inhibitors Market Size Share by Country (2017-2028)
    Figure 56. Turkey Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. UAE Kinase Inhibitors Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. Merck Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 60. Novartis Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 61. Pfizer Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 62. Sanofi Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 63. GlaxoSmithKline Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 64. Biogen Idec Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 65. Bayer Healthcare Pharmaceuticals Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 66. Johnson Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 67. Tolero Pharmaceutical Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 68. Astellas Pharma Inc Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 69. Eli Lilly and Co Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 70. Incyte Corp Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 71. AstraZeneca Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 72. Bristol-Myers Squibb Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 73. Boehringer Ingelheim International GmbH Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 74. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 75. Eisai Co., Ltd. Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 76. BerGenBio Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 77. Rigel Pharmaceuticals Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 78. Mirati Therapeutics Revenue Growth Rate in Kinase Inhibitors Business (2017-2022)
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Novartis
Pfizer
Sanofi
GlaxoSmithKline
Biogen Idec
Bayer Healthcare Pharmaceuticals
Johnson
Tolero Pharmaceutical
Astellas Pharma Inc
Eli Lilly and Co
Incyte Corp
AstraZeneca
Bristol-Myers Squibb
Boehringer Ingelheim International GmbH
F. Hoffmann-La Roche Ltd
Eisai Co., Ltd.
BerGenBio
Rigel Pharmaceuticals
Mirati Therapeutics
Frequently Asked Questions
Kinase Inhibitors report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Kinase Inhibitors report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Kinase Inhibitors report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Kresoxim Methyl

Kresoxim Methyl market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

Label Free Detection

Label Free Detection market is segmented by players, region (country), by Type and by Application ... Read More

Lactate Norfloxacin

Lactate Norfloxacin market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More

Lambda Cyhalothrin

Lambda Cyhalothrin market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More